Trial
NCT03579160
Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Wound of Skin
Intervention
0.25% timolol gel with full-thickness skin grafts
Why stopped
Due to the insufficient accrual rate and strategic reasons to focus our efforts on higher impact research projects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-09